Started getting Red; Swollen around the injection site; Hard around the injection site; red rash; itches; Area is lumpy, when it is touched; arm was slightly sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was slightly sore), ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site) and RASH ERYTHEMATOUS (red rash) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was slightly sore). On 01-Feb-2021, the patient experienced ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site), RASH ERYTHEMATOUS (red rash), PRURITUS (itches) and INJECTION SITE MASS (Area is lumpy, when it is touched). At the time of the report, PAIN IN EXTREMITY (arm was slightly sore), ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site), RASH ERYTHEMATOUS (red rash), PRURITUS (itches) and INJECTION SITE MASS (Area is lumpy, when it is touched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 02-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was slightly sore), ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site) and RASH ERYTHEMATOUS (red rash) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was slightly sore). On 01-Feb-2021, the patient experienced ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site), RASH ERYTHEMATOUS (red rash), PRURITUS (itches) and INJECTION SITE MASS (Area is lumpy, when it is touched). At the time of the report, PAIN IN EXTREMITY (arm was slightly sore), ERYTHEMA (Started getting Red), VACCINATION SITE SWELLING (Swollen around the injection site), VACCINATION SITE INDURATION (Hard around the injection site), RASH ERYTHEMATOUS (red rash), PRURITUS (itches) and INJECTION SITE MASS (Area is lumpy, when it is touched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.